Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial

C. Cremolini; D. Rossini; E. Dell'Aquila; S. Lonardi; E. Conca; M. Del Re; A. Busico; F. Pietrantonio; R. Danesi; G. Aprile; E. Tamburini; C. Barone; G. Masi; F. Pantano; F. Pucci; D.C. Corsi; N. Pella; F. Bergamo; E. Rofi; C. Barbara; A. Falcone; D. Santini

doi:10.1001/jamaoncol.2018.5080

Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial

C. Cremolini, D. Rossini, E. Dell'Aquila, S. Lonardi, E. Conca, M. Del Re, A. Busico, F. Pietrantonio, R. Danesi, G. Aprile, E. Tamburini, C. Barone, G. Masi, F. Pantano, F. Pucci, D.C. Corsi, N. Pella, F. Bergamo, E. Rofi, C. BarbaraA. Falcone, D. Santini

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	343-350
Number of pages	8
Journal	JAMA oncology
Volume	5
Issue number	3
DOIs	https://doi.org/10.1001/jamaoncol.2018.5080
Publication status	Published - 2019

Access to Document

10.1001/jamaoncol.2018.5080

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057127256&doi=10.1001%2fjamaoncol.2018.5080&partnerID=40&md5=468e139817b470085661b5d6bdfe8f3c

Cite this

Cremolini, C., Rossini, D., Dell'Aquila, E., Lonardi, S., Conca, E., Del Re, M., Busico, A., Pietrantonio, F., Danesi, R., Aprile, G., Tamburini, E., Barone, C., Masi, G., Pantano, F., Pucci, F., Corsi, D. C., Pella, N., Bergamo, F., Rofi, E., ... Santini, D. (2019). Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial. JAMA oncology, 5(3), 343-350. https://doi.org/10.1001/jamaoncol.2018.5080

Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial. / Cremolini, C.; Rossini, D.; Dell'Aquila, E.; Lonardi, S.; Conca, E.; Del Re, M.; Busico, A.; Pietrantonio, F.; Danesi, R.; Aprile, G.; Tamburini, E.; Barone, C.; Masi, G.; Pantano, F.; Pucci, F.; Corsi, D.C.; Pella, N.; Bergamo, F.; Rofi, E.; Barbara, C.; Falcone, A.; Santini, D.

In: JAMA oncology, Vol. 5, No. 3, 2019, p. 343-350.

Research output: Contribution to journal › Article › peer-review

Cremolini, C, Rossini, D, Dell'Aquila, E, Lonardi, S , Conca, E, Del Re, M, Busico, A, Pietrantonio, F, Danesi, R, Aprile, G, Tamburini, E , Barone, C , Masi, G, Pantano, F, Pucci, F, Corsi, DC, Pella, N, Bergamo, F, Rofi, E, Barbara, C, Falcone, A & Santini, D 2019, 'Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial', JAMA oncology, vol. 5, no. 3, pp. 343-350. https://doi.org/10.1001/jamaoncol.2018.5080

Cremolini, C. ; Rossini, D. ; Dell'Aquila, E. ; Lonardi, S. ; Conca, E. ; Del Re, M. ; Busico, A. ; Pietrantonio, F. ; Danesi, R. ; Aprile, G. ; Tamburini, E. ; Barone, C. ; Masi, G. ; Pantano, F. ; Pucci, F. ; Corsi, D.C. ; Pella, N. ; Bergamo, F. ; Rofi, E. ; Barbara, C. ; Falcone, A. ; Santini, D. / Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial. In: JAMA oncology. 2019 ; Vol. 5, No. 3. pp. 343-350.

@article{a22e067b959b48e397fe856da9582113,

title = "Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial",

author = "C. Cremolini and D. Rossini and E. Dell'Aquila and S. Lonardi and E. Conca and {Del Re}, M. and A. Busico and F. Pietrantonio and R. Danesi and G. Aprile and E. Tamburini and C. Barone and G. Masi and F. Pantano and F. Pucci and D.C. Corsi and N. Pella and F. Bergamo and E. Rofi and C. Barbara and A. Falcone and D. Santini",

note = "Cited By :16 Export Date: 11 February 2020",

year = "2019",

doi = "10.1001/jamaoncol.2018.5080",

language = "English",

volume = "5",

pages = "343--350",

journal = "JAMA oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "3",

}

TY - JOUR

T1 - Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial

AU - Cremolini, C.

AU - Rossini, D.

AU - Dell'Aquila, E.

AU - Lonardi, S.

AU - Conca, E.

AU - Del Re, M.

AU - Busico, A.

AU - Pietrantonio, F.

AU - Danesi, R.

AU - Aprile, G.

AU - Tamburini, E.

AU - Barone, C.

AU - Masi, G.

AU - Pantano, F.

AU - Pucci, F.

AU - Corsi, D.C.

AU - Pella, N.

AU - Bergamo, F.

AU - Rofi, E.

AU - Barbara, C.

AU - Falcone, A.

AU - Santini, D.

N1 - Cited By :16 Export Date: 11 February 2020

PY - 2019

Y1 - 2019

U2 - 10.1001/jamaoncol.2018.5080

DO - 10.1001/jamaoncol.2018.5080

M3 - Article

VL - 5

SP - 343

EP - 350

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

IS - 3

ER -